Clinical Trial Update: Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update analyzes expression of specific biomarkers and their prognostic significance in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatocellular Carcinoma | Status: COMPLETED